Publications by authors named "Shanthi Viswanathan"

Claim this Profile
R
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings.
Nick Rijke, Bassem I Yamout, Deanna Saylor, Francesco Nonino, Graziella Filippini, Shanthi Viswanathan

Mult Scler Relat Disord· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region.
Ho Jin Kim, Suzanne J Hodgkinson, Long-Sun Ro, Rocksy Fransisca V Situmeang, Sasitorn Siritho, Shanthi Viswanathan

Mult Scler Relat Disord· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-Controlled Release of Bromelain from κ-Carrageenan Nanocomposite Hydrogels Reinforced with Bio-Derived Nanofillers.
Marisa Faria, Deepa Bhanumathyamma, Gladys Maria Reji, Aswin Sreenivas Baluseri Kuttiyatt, Ghanashyam Sivaprasad, Shanthi Prabha Viswanathan

Int J Mol Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unemployment, work hour reduction, and income loss: An international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder.
Andrew Siyoon Ham, Isabella Gomez Hjerthen, De-Cai Tian, Hongfei Gu, Wen Gao, Shanthi Viswanathan

Mult Scler· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.
Xavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, Georgina Arrambide, Marcello Moccia, Shanthi Viswanathan

Lancet Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income country.
Elaine Chew, Dalia L Rotstein, Shanthi Viswanathan

Mult Scler Relat Disord· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for essential medicines for multiple sclerosis in low-resource settings.
Deanna Saylor, Nick Rijke, Jennifer McDonell, Joanna Laurson-Doube, Jagannadha Avasarala, Shanthi Viswanathan

Mult Scler· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort study.
Andrew Siyoon Ham, Isabella Gomez Hjerthen, Akshatha Sudhir, Lekha Pandit, Y Muralidhar Reddy, Shanthi Viswanathan

Mult Scler· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia.
Adeline Su Lyn Ng, Ai Huey Tan, Yi Jayne Tan, Jia Lun Lim, Michelle Mulan Lian, Shanthi Viswanathan

Mov Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential diagnosis of suspected multiple sclerosis: global health considerations.
Jorge Correale, Andrew J Solomon, Jeffrey A Cohen, Brenda L Banwell, Fernando Gracia, Shanthi Viswanathan

Lancet Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement.
Shanthi Viswanathan, Lavanya Vijayasingham, Joanna Laurson-Doube, Amy M L Quek, Kevin Tan

Mult Scler Relat Disord· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation.
Bassem I Yamout, Shanthi Viswanathan, Joanna Laurson-Doube, Dilraj Sokhi

Mult Scler· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study.
Sin Hong Chew, Hairuddin Bin Achmad Sankala, Elaine Chew, Md Hanif Bin Md Arif, Norzaini Rose Mohd Zain, Shanthi Viswanathan

Mult Scler Relat Disord· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive Wetland Weeds Derived Biochar Properties Affecting Soil Carbon Dynamics of South Indian Tropical Ultisol.
Shanthi Prabha Viswanathan, Gopika Vijayakumar Njazhakunnathu, Sreekanth Prakasan Neelamury, Babu Padmakumar, Thomas Paili Ambatt

Environ Manage· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facilities, selection, outcome measurement, and limitations of therapeutic plasma exchange for neuroimmunological disorders: The South East Asian survey study.
Natthapon Rattanathamsakul, Sasitorn Siritho, Shanthi Viswanathan, Fu Liong Hiew, Metha Apiwattanakul

J Clin Apher· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition.
Andrew J Solomon, Ruth Ann Marrie, Shanthi Viswanathan, Jorge Correale, Melinda Magyari

Neurology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Neuropathy in Children with Chronic Kidney Disease: Are we Looking Enough? An Editorial.
Shanthi Viswanathan

Ann Indian Acad Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Covid-19 on the therapeutic plasma exchange service within the South East Asian region: Consensus recommendations and global perspectives.
Shanthi Viswanathan, Fu Liong Hiew, Sasitorn Siritho, Metha Apiwattanakul, Kevin Tan

J Clin Apher· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendation on the use of therapeutic plasma exchange for adult neurological diseases in Southeast Asia from the Southeast Asia therapeutic plasma exchange consortium.
Fu Liong Hiew, Win Min Thit, Mathew Alexander, Umapathi Thirugnanam, Sasitorn Siritho, Shanthi Viswanathan

J Cent Nerv Syst Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson's disease in patients of Malay ancestry.
Jia Lun Lim, Ebonne Yulin Ng, Shen-Yang Lim, Ai Huey Tan, Zariah Abdul-Aziz, Shanthi Viswanathan

Neurol Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toluene-induced leukodystrophy from glue sniffing.
Yue Hui Lau, Ahmad Shahir Mawardi, Norzaini Rose Zain, Shanthi Viswanathan

Pract Neurol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical use of off-label disease-modifying therapies for multiple sclerosis.
Joanna Laurson-Doube, Nick Rijke, Anne Helme, Peer Baneke, Brenda Banwell, Shanthi Viswanathan

Mult Scler· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of emerging rabies: a neglected tropical disease in Sarawak, Malaysia.
Benjamin Ng Han Sim, Benjamin Ng Wei Liang, Wong Sheau Ning, Shanthi Viswanathan

J R Coll Physicians Edinb· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension.
Ho Jin Kim, Ichiro Nakashima, Shanthi Viswanathan, Kai-Chen Wang, Shulian Shang

Mult Scler Relat Disord· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial.
Jacqueline Palace, Dean M Wingerchuk, Kazuo Fujihara, Achim Berthele, Celia Oreja-Guevara, Shanthi Viswanathan

Mult Scler Relat Disord· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis